Health Condition 1: G00-G99- Diseases of the nervous system Health Condition 2: G89-G99- Other disorders of the nervous system
Conditions
Interventions
Intervention1: Efficasy of combined injection Ketamine and Dexmedetomidine intravenously for sedation in pediatric patients undergoing MRI: Injection Ketamine 0.5-1mg/kg and injection Dexmedetomidine
Sponsors
Government Medical College Vadodara
Eligibility
Inclusion criteria
Inclusion criteria: Age group 6months to 8 years of either gender Patients with ASA I-II-III status Scheduleded to undergo MRI with time less than 60 mins Able to provide written informed consent by relatives
Exclusion criteria
Exclusion criteria: Not able to provide written informed consent by relatives Hypersensitivity to drugs used in the study Presence of congenital heart diseases and pulmonary diseases Recent upper respiratory tract infections or pneumonia Facial malformation and anticipatory difficult intubation Extreme tonsillar hypertrophy Raised intracranial tension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the quality of sedation acheived by intamuscular versus intravenous injection ketamine and inj dexmedetomidine combination in peadiatric patients undergoing MRI as assessed by image qualityTimepoint: 3 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic stablity heart rate and oxygen saturation Duration of MRI scan and number of rescue bolus required Recovery profile according to modified aldrete score Adverse effects like bradycardia and desaturation and any other complicationsTimepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr Kumud S Ganvit
Government Medical College Vadodara
Outcome results
None listed